Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
80.38
+0.91 (1.15%)
Dec 5, 2025, 4:00 PM EST - Market closed
Monopar Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -19.44 | -15.59 | -8.4 | -10.52 | -9.1 | -6.3 | |
| Stock-Based Compensation | 4.01 | 1.14 | 1.9 | 1.64 | 1.47 | 1.32 | |
| Other Operating Activities | 4.55 | 4.55 | - | - | - | -0.12 | |
| Change in Accounts Payable | 0.78 | 0.51 | -1.33 | 1.48 | 0.4 | 0.45 | |
| Change in Other Net Operating Assets | -0.74 | 2.98 | -0.02 | 0.17 | -0.09 | -0 | |
| Operating Cash Flow | -10.83 | -6.4 | -7.86 | -7.23 | -7.32 | -4.66 | |
| Investment in Securities | -15.6 | -14.34 | 4.93 | -4.92 | - | - | |
| Investing Cash Flow | -15.6 | -14.34 | 4.93 | -4.92 | - | - | |
| Long-Term Debt Issued | - | - | - | - | - | 0.12 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | 0.12 | |
| Issuance of Common Stock | 184 | 59.4 | 2.07 | 0.11 | 11.28 | 8.43 | |
| Repurchase of Common Stock | -35.9 | -0.1 | -0.05 | -0.08 | -0.06 | - | |
| Other Financing Activities | - | - | - | - | -0.34 | -0.37 | |
| Financing Cash Flow | 148.1 | 59.29 | 2.03 | 0.03 | 10.88 | 8.18 | |
| Foreign Exchange Rate Adjustments | -0.01 | 0 | -0.02 | -0 | 0 | 0 | |
| Net Cash Flow | 121.66 | 38.55 | -0.92 | -12.12 | 3.57 | 3.52 | |
| Cash Income Tax Paid | - | - | - | - | - | -0.01 | |
| Levered Free Cash Flow | -8.45 | -5.48 | -5.01 | -3.22 | -3.99 | -2.34 | |
| Unlevered Free Cash Flow | -8.45 | -5.48 | -5.01 | -3.22 | -3.99 | -2.34 | |
| Change in Working Capital | 0.05 | 3.49 | -1.35 | 1.65 | 0.32 | 0.44 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.